Market cap
$128 Mln
Revenue (TTM)
$80 Mln
P/E Ratio
--
P/B Ratio
0.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 0.00 | 100.00 | 201.39 | -- | 128.83 |
| EBIT | -135.24 | -3,048.08 | -43.29 | -225.36 | -207.37 |
| Net Profit | -179.51 | -184.74 | -30.42 | 14.04 | -38.85 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-22 | Dec-21 | Dec-20 |
| EBIT-Margin
| -231.23 | -231.23 | -127.13 | -179.98 | -386.59 |
| Net Margin
| -99.20 | -3,805.28 | -- | -1.27 | -197.14 |
| Return on equity
| 37.40 | -244.83 | -12.05 | -0.41 | 124.68 |
| Return on Capital
| 37.40 | -244.83 | -12.05 | -0.41 | 124.68 |
| Return on Assets
| -9.44 | -31.92 | -9.25 | -0.18 | -18.89 |
| Debt to Equity (x)
| -- | -- | -- | -- | -- |
Profitability
ROCE
-12.05
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
-12.05
|
-0.41
|
124.68
|
-1,228.08
|
-108.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-12.05
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
-12.05
|
-0.41
|
124.68
|
-1,228.08
|
-108.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-9.25
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
-9.25
|
-0.18
|
-18.89
|
-95.16
|
-36.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-127.13
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
-127.13
|
-179.98
|
-386.59
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-49.71
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
-49.71
|
-1.27
|
-197.14
|
-10,847.63
|
-4,175.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.51
--
Year on year growth in net sales
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
0.51
|
1.36
|
--
|
--
|
-1.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-6.45
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
-6.45
|
-9.98
|
-225.00
|
239.59
|
-24.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-5,817.86
--
Year on year growth in profit after tax
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
-5,817.86
|
98.50
|
79.17
|
-219.06
|
-16.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.10
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
6.10
|
17.77
|
3.48
|
6.39
|
8.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
2.06
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
2.06
|
92.27
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.19
--
Sales / Average Total Assets
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
0.19
|
0.15
|
0.09
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
115.59
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
115.59
|
337.03
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
--
|
--
|
--
|
24.21
|
29.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
EV/EBITDA
3.28
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
3.28
|
3.41
|
1.21
|
-1.38
|
2.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|